DEVELOPING STRATEGIES TO OVERCOME PROSTATE STROMAL- DERIVED NRG1-MEDIATED RESISTANCE TO AR BLOCKADE IN HIGH-RISK LOCALLY ADVANCED PROSTATE CANCER.

$1,327,473FY2021Department of the ArmyDOD

Sloan-Kettering Institute For Cancer Research

Investigators